FORT WORTH, Texas--(BUSINESS WIRE)--April 25, 2005--Alcon, Inc., (NYSE:ACL) announced the launch of the AcrySof(R) ReSTOR(R) Intraocular Lens (IOL) at a press conference during the American Society of ...

Basel, Switzerland, April 16, 2015-Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof ® IQ ReSTOR ® ...

For years, patients who underwent cataract surgery had to wear glasses or contact lenses afterwards to see clearly. The newly developed ReSTOR® lens has overcome this problem, allowing patients to see ...

The US Food and Drug Administration (FDA) has approved a new intraocular lens (IOL) designed to address presbyopia and pre-existing corneal astigmatism at the time of cataract surgery in adults. The ...

Here are 17 facts and business and legal issues about premium intraocular lenses, a recent technology that can free many cataract surgery patients from having to wear eyeglasses. 1. In one of the few ...

(RTTNews) - Alcon, a division of Novartis, announced it has received approval from the US FDA for its AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens with ACTIVEFOCUS optical design for ...

LOS ANGELES — The accommodative Crystalens intraocular lens (IOL) (Bausch + Lomb) achieved better intermediate visual acuity but not as good near visual acuity compared with the ReStor +3 multifocal ...

Bossier City, La.-based Zaffater Eye Center’s Norman Zaffater, MD, became the first physician in the Shreveport-Bossier area to implant the ReSTOR Multifocal TORIC intraocular lens, according to the ...

The eye's natural crystalline lens can be replaced with an artificial lens—known as an intraocular lens—to restore clarity and lead to a vast improvement in quality of life for patients with cataracts ...

If you are over the age of 65, Medicare will cover the cost of cataract surgery along with a conventional "monofocal" IOL. Patients electing monofocal IOLs typically have both eyes corrected for clear ...

Please provide your email address to receive an email when new articles are posted on . In 2013, Malvina B. Eydelman, MD, director of the FDA’s Division of Ophthalmic and Ear, Nose and Throat Devices, ...

Intraocular lenses (IOLs), implanted in the eye as treatment for cataracts or myopia, are a growing global market in an ageing population, one estimated to be worth more than $4.5 billion by 2022.